PortfoliosLab logoPortfoliosLab logo
CME vs. NU
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CME vs. NU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CME Group Inc. (CME) and Nu Holdings Ltd. (NU). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CME achieves a -5.50% return, which is significantly higher than NU's -30.70% return.


CME

1D
-2.09%
1M
-10.39%
YTD
-5.50%
6M
-4.13%
1Y
-4.58%
3Y*
15.54%
5Y*
7.50%
10Y*
14.50%

NU

1D
-3.09%
1M
-15.94%
YTD
-30.70%
6M
-30.20%
1Y
-4.53%
3Y*
15.70%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CME vs. NU - Yearly Performance Comparison


2026 (YTD)20252024202320222021
CME
CME Group Inc.
-5.50%19.83%15.41%31.32%-22.89%1.81%
NU
Nu Holdings Ltd.
-30.70%61.58%24.37%104.67%-56.61%-9.20%

Correlation

The correlation between CME and NU is -0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.07

Correlation (3Y)
Calculated over the trailing 3-year period

-0.05

Correlation (All Time)
Calculated using the full available price history since Dec 10, 2021

0.07

The correlation between CME and NU shifts across timeframes, from -0.07 (1 year) to 0.07 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CME:

$91.54B

NU:

$56.96B

EPS

CME:

$11.75

NU:

$0.65

PE Ratio

CME:

21.45

NU:

17.87

PEG Ratio

CME:

1.87

NU:

0.27

PS Ratio

CME:

13.46

NU:

3.24

PB Ratio

CME:

3.44

NU:

4.52

Total Revenue (TTM)

CME:

$6.76B

NU:

$17.54B

Gross Profit (TTM)

CME:

$5.84B

NU:

$7.67B

EBITDA (TTM)

CME:

$5.69B

NU:

$4.14B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CME vs. NU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CME
CME Risk / Return Rank: 3030
Overall Rank
CME Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
CME Sortino Ratio Rank: 2727
Sortino Ratio Rank
CME Omega Ratio Rank: 2727
Omega Ratio Rank
CME Calmar Ratio Rank: 3535
Calmar Ratio Rank
CME Martin Ratio Rank: 2828
Martin Ratio Rank

NU
NU Risk / Return Rank: 3636
Overall Rank
NU Sharpe Ratio Rank: 3737
Sharpe Ratio Rank
NU Sortino Ratio Rank: 3333
Sortino Ratio Rank
NU Omega Ratio Rank: 3333
Omega Ratio Rank
NU Calmar Ratio Rank: 3838
Calmar Ratio Rank
NU Martin Ratio Rank: 3737
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CME vs. NU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CME Group Inc. (CME) and Nu Holdings Ltd. (NU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CMENUDifference
Sharpe ratioReturn per unit of total volatility

-0.11

Sortino ratioReturn per unit of downside risk

-0.28

Omega ratioGain probability vs. loss probability

0.98

1.01

-0.03

Calmar ratioReturn relative to maximum drawdown

-0.21

-0.12

-0.10

Martin ratioReturn relative to average drawdown

-0.72

-0.31

-0.42

CME vs. NU - Sharpe Ratio Comparison

The current CME Sharpe Ratio is -0.23, which is lower than the NU Sharpe Ratio of -0.12. The chart below compares the historical Sharpe Ratios of CME and NU, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CMENUDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.23

-0.12

-0.11

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.38

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.61

Sharpe Ratio (All Time)

Calculated using the full available price history

0.59

0.05

+0.54

Drawdowns

CME vs. NU - Drawdown Comparison

The maximum CME drawdown since its inception was -77.50%, which is greater than NU's maximum drawdown of -72.07%. Use the drawdown chart below to compare losses from any high point for CME and NU.


Loading charts...

Drawdown Indicators


CMENUDifference

Max Drawdown

Largest peak-to-trough decline

-77.50%

-72.07%

-5.43%

Max Drawdown (1Y)

Largest decline over 1 year

-21.42%

-38.17%

+16.75%

Max Drawdown (3Y)

Largest decline over 3 years

-21.42%

-39.58%

+18.16%

Max Drawdown (5Y)

Largest decline over 5 years

-31.74%

Max Drawdown (10Y)

Largest decline over 10 years

-37.36%

Current Drawdown

Current decline from peak

-20.95%

-38.17%

+17.22%

Average Drawdown

Average peak-to-trough decline

-20.69%

-29.77%

+9.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.35%

14.69%

-8.34%

Volatility

CME vs. NU - Volatility Comparison

The current volatility for CME Group Inc. (CME) is 10.21%, while Nu Holdings Ltd. (NU) has a volatility of 14.24%. This indicates that CME experiences smaller price fluctuations and is considered to be less risky than NU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CMENUDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.21%

14.24%

-4.03%

Volatility (6M)

Calculated over the trailing 6-month period

16.89%

28.87%

-11.98%

Volatility (1Y)

Calculated over the trailing 1-year period

20.38%

39.10%

-18.72%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.06%

58.43%

-38.37%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.89%

58.43%

-34.54%

Dividends

CME vs. NU - Dividend Comparison

CME's dividend yield for the trailing twelve months is around 4.44%, while NU has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
CME
CME Group Inc.
4.44%1.83%4.48%4.58%5.05%3.00%3.24%2.74%2.42%4.20%4.90%5.41%
NU
Nu Holdings Ltd.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

CME vs. NU - Financials Comparison

This section allows you to compare key financial metrics between CME Group Inc. and Nu Holdings Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B20222023202420252026
1.88B
4.98B
(CME) Total Revenue
(NU) Total Revenue
Values in USD except per share items

CME vs. NU - Profitability Comparison

The chart below illustrates the profitability comparison between CME Group Inc. and Nu Holdings Ltd. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%90.0%20222023202420252026
88.1%
40.2%
Portfolio components
CME - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported a gross profit of 1.66B and revenue of 1.88B. Therefore, the gross margin over that period was 88.1%.

NU - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nu Holdings Ltd. reported a gross profit of 2.00B and revenue of 4.98B. Therefore, the gross margin over that period was 40.2%.

CME - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported an operating income of 1.31B and revenue of 1.88B, resulting in an operating margin of 69.7%.

NU - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nu Holdings Ltd. reported an operating income of 954.31M and revenue of 4.98B, resulting in an operating margin of 19.2%.

CME - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported a net income of 1.15B and revenue of 1.88B, resulting in a net margin of 61.4%.

NU - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nu Holdings Ltd. reported a net income of 872.06M and revenue of 4.98B, resulting in a net margin of 17.5%.


Frequently Asked Questions


CME and NU have a correlation of -0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NU has higher volatility (14.24%) compared to CME (10.21%). In terms of maximum drawdown, CME dropped -77.50% vs NU's -72.07%.

NU currently has the higher Sharpe Ratio (-0.12 vs -0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CME and NU

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer